Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vanesa Castano"'
Publikováno v:
Animal Cognition. 25:519-527
Innovation, a process that plays an important role in the ecology and evolution of species, is considered an expression of behavioral flexibility in animals. Here we analyzed innovative problem-solving ability and performance enhancement through lear
Autor:
María Cabrejo, Horacio Fernandez Grecco, Ana Ines Varela, Astrid Pavlovsky, Eriberto Roveri, Romina Mariano, Francisco Sakamoto, Rossana L. Taus, Isolda Fernandez, Virginia Prates, Federico Sackmann, Silvia Rudoy, G. Remaggi, Ider Cerutti, Soledad Zabaljauregui, María Florencia Casale, Nicolas Matias Kurgansky, Ana Lisa Basquiera, Gustavo Milone, Pedro Negri, Vanesa Castano, Maximiliano Luis Riddick, Vanina Cabane, Lucia Zoppegno, Claudia Venturini, Silvia Saba, Santiago Pavlovsky
Publikováno v:
British Journal of Haematology. 185:865-873
The role of Ann Arbor staging in determining treatment intensity after achieving a negative positron emission tomography (PET) has not been established in classical Hodgkin lymphoma (cHL). Patients with stage I–IV cHL, received three cycles of ABVD
Autor:
Juan Pablo Seco Pon, María Eugenia Becherucci, Carla Ángela Paterlini, Agustina Quadri Adrogué, Melina Vanesa Castano, Francisco Zumpano, Germán Oscar García
Publikováno v:
Ocean & Coastal Management. 220:106070
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Ana Lisa Basquiera, Santiago Pavlovsky, Ider Cerutti, Silvia Rudoy, Francisco Lastiri, Lourdes Valles, Isolda Fernandez, Lucia Zoppegno, Vanesa Castano, Astrid Pavlovsky, Federico Sackmann, Gustavo Milone, Andrea Rodriguez, Virginia Prates, Miguel A. Pavlovsky
Publikováno v:
Blood. 116:1772-1772
Abstract 1772 Background: Hodgkin Lymphoma (HL) is the most curable type of Lymphoma with an overall survival at 5 years of 80%. ABVD can be considered as gold standard for first line treatment for all stages of HL. Dividing patients (pts.) in differ